Abstract
Neurofibromin is one of the few Ras-GTP activating proteins (Ras-GAPs) expressed in the brain. Disruption of its expression leads to the detrimental disease neurofibromatosis type 1 (NF1). Many studies have revealed the crucial role of NF1 in developing and adult tissues. However, these studies have focused on the expression of the entire NF1 gene and largely ignored the role of an alternative splicing event that controls the Ras-GAP function of neurofibromin. The focus of this chapter is NF1 exon 23a. This exon is located in the GAP-related domain (GRD) of neurofibromin. Its expression level, indicated by the percentage of its inclusion in the NF1 mRNA transcripts, has a profound effect on the Ras-GAP function of neurofibromin. In this chapter, we review the expression pattern of exon 23a and the molecular mechanisms that regulate its expression. We then discuss the role of its expression in Ras/ERK signaling and learning behaviors in mice. Lastly, we propose a few directions for future studies.
Keywords
- NF1
- alternative splicing
- exon 23a
- Ras-GAP
- learning behaviors
- mouse
1. Introduction
Neurofibromatosis type 1 (NF1) is a genetic disorder that affects approximately 1 in 2000–4000 individuals [1]. The disease hallmark includes tumors in the nervous system, most commonly, benign peripheral nerve tumors or neurofibromas, and café-au-lait macules [1]. In addition, many NF1 patients exhibit cognitive and behavioral problems, bone abnormalities and hypertension [1].
The underlying cause of the NF1 disease is the germline mutation in one of the two alleles of the
Proper expression of the GRD is critical to achieving the optimal Ras-GAP function of neurofibromin. In mammals, the
In addition to transcriptional regulation, the expression output of the
In this chapter, we will focus on exon 23a and discuss the following questions. What is the expression pattern of this exon? How is its expression regulated? How does its expression affect the Ras-GAP function of neurofibromin? How does its expression affect the signaling pathways downstream of Ras? How does disruption of its expression affect animal behaviors
2. The functional role of regulated expression of NF1 exon 23a
2.1 Expression of Nf1 exon 23a in mouse
RT-PCR analysis indicated that the alternative inclusion of exon 23a is tightly regulated in tissue- and developmental stage-specific patterns. In adults, exon 23a is predominantly skipped in the brain and testis leading to production of the type 1 NF1 isoform, while in other tissues, exon 23a is included to various extents leading to production of the type 2 isoform [6, 12, 13]. In adult mouse, exon 23a is included at 8% in the testis, 11% in the brain, 42% in the spleen, 58% in the heart, 62% in the liver, 78% in the kidney and 82% in the lung [14]. Within the brain, exon 23a is least included in hippocampus at 2–4% and slightly more included in the cortex at 10% [15]. In primary mouse cardiomyocytes, exon 23a is included at 70% [16].
During development, in the mouse brain, a switch from the isoform 2 to isoform 1 occurs during early embryonic development between day E10 and E11 [6, 13]. The biological significance of this switch has not been investigated.
2.2 Molecular mechanisms regulating alternative splicing of exon 23a
Most of our experiments were conducted using human
The differential splicing of exon 23a is under complex control by two distinct mechanisms (Figure 2). The first mechanism involves several regulatory RNA-binding proteins (RBPs) which promote either its skipping or inclusion (Figure 2A). Two families of RBPs which promote the skipping of exon 23a have been identified, Hu proteins, also known as ELAV-like proteins, and CUG-BP1 and ETR-3 like factors (CELF). Hu proteins bind to AU-rich regions of RNA both upstream and downstream of exon 23a while CELF proteins bind to UG-rich motifs upstream of exon 23a (Figure 2A) [18, 19, 20]. Mechanistically, upstream of exon 23a, Hu and CELF proteins function to block the splicing factor U2AF from binding to the 3′ splice site, while downstream of exon 23a, Hu proteins block splicing factors U1 and U6 snRNP complexes from binding to the 5′ splicing site [18, 20]. Two additional families of RBPs, TIA-1/TIAR and muscleblind-like (MBNL) proteins, on the other hand, promote the inclusion of exon 23a (Figure 2A). TIA-1/TIAR proteins, in direct competition for binding with Hu proteins, bind to the U-rich sequence downstream of exon 23a, promoting the U1 and U6 snRNP binding at the 5′ splice site and inclusion of the exon [18]. MBNL proteins binds to a sequence upstream of exon 23a to promote its inclusion (Figure 2A) [21].
The second mechanism involves epigenetic regulation of alternative splicing, at the chromatin level, through altering histone modifications and transcriptional elongation rate (Figure 2B). One of the models that explains the epigenetic regulation of splicing is the kinetics coupling model of transcription and splicing [22]. This model predicts that faster transcriptional elongation rate of RNAPII promotes skipping of an alternative exon, which is usually surrounded by suboptimal splicing signals, as in the case of NF1 exon 23a [23]. One of the factors regulating transcriptional elongation rate is the “openness” of chromatin modulated by histone acetylation [22]. The higher level of histone acetylation is correlated with more relaxed configuration of the chromatin, which allows RNAPII move faster during transcription. Exon 23a is subjected to this mode of regulation in two different ways as shown in Figure 2B. Studies using mouse primary cardiomyocytes where exon 23a is normally included at 70% demonstrated that an increase in Ca2+ by KCl-induced depolarization led to a significant reduction of inclusion to 10–15% through increasing histone acetylation on the body of the entire
2.3 Role of exon 23a expression in cell signaling regulation
In order to uncover the biological importance of exon 23a inclusion, our laboratory generated mutant embryonic stem (ES) cell lines through the classical gene-targeting knock-in approach [23]. We generated two contrasting mouse ES cell lines, one showing 100% exon 23a inclusion in the endogenously expressed
We then differentiated these ES cells into CNS-like neurons following an established protocol [25]. In this two week procedure, mouse ES cells were first grown in a non-adherent dish in the presence of retinoic acid to form cellular aggregates, which were then dissociated and plated on laminin-coated tissue culture plates in neuronal culture medium that support neural differentiation and maturation. This procedure was shown to produce pyramidal neurons with >90% homogeneity [25]. When the two mutant
Using the
2.4 Role of exon 23a expression in mouse learning and memory behaviors
To explore the link between exon 23a regulation of Ras and cognitive behaviors, a battery of learning and memory tests were conducted comparing the wildtype and mutant
To test short-term and long-term spatial memory, a T-maze and Morris water maze test were conducted, respectively. T-maze test is used to examine the short-term spatial memory. In this test, mice were placed in a T-shaped maze and allowed to explore the maze freely for 10 minutes while one of the arms was closed. Following the exploration, mice were returned to their home cage for 2 hours and then put back in the T-maze with all three arms open. Once put in the T-maze, mice were video recorded. The memory measurement was calculated as the time spent in the previously closed arm divided by the overall time spent in both arms, which was expected to be 50% by chance. The wild type mice were more likely to explore an unfamiliar lever arm than a familiar one, a preference indicative of an active short-term memory. The mutant
Morris water maze test is used to examine the long-term spatial memory. In this test, mice were trained in a small water pool in a well-lit room replete of visual cues. A hidden escape platform was placed 0.5 cm beneath the water level in a particular location in the pool. Animals were tested for three trials per day over 4 days. For these trials, mice were placed in the water and allowed to swim for 60 seconds. If mice did not find the platform during the allotted time, they were guided toward it, and held for 15 seconds on the platform. Swim time and path length were recorded. Following the final session, the platform was removed for a probe trial to test for spatial strategy and retention. During the probe test, mice were allowed to swim for 60 seconds without the possibility of escape; the percentage of time spent in the quadrant where the platform was previously located was measured. In this test, the mutant
The mutant
3. Conclusions and future studies
Our studies have demonstrated that
Given the role of Ras/ERK in many brain functions, it is reasonable to predict additional behavioral defects in the mutant
The behavioral defects observed in the mutant
Lastly, the ratio of neurofibromin isoform 1 and isoform 2 in neuronal tissues in NF1 patients has never been examined. It will be interesting to study if the ratio changes in patients and if so, how does the change contributes to the disease development.
Acknowledgments
We thank the former members of the Lou laboratory, Victoria Fleming, Xuan Gao, Melissa Hinman, Hieu Nguyen, Alok Sharma, Hua-Lin Zhou and Hui Zhu, for their work discussed in this chapter. Karl Mader was supported by a Cystic Fibrosis Foundation pilot grant to Hua Lou as part of the CWRU RDP, DRUMM19R0.
References
- 1.
Ly, K.I. and J.O. Blakeley, The diagnosis and Management of Neurofibromatosis Type 1. Med Clin North Am, 2019. 103(6): p. 1035-1054 - 2.
Ballester, R., et al., The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell, 1990. 63(4): p. 851-859 - 3.
Martin, G.A., et al., The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell, 1990. 63(4): p. 843-849 - 4.
Xu, G.F., et al., The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell, 1990. 63(4): p. 835-841 - 5.
DeClue, J.E., et al., Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell, 1992. 69(2):p. 265-273 - 6.
Gutmann, D.H., J.L. Cole, and F.S. Collins, Expression of the neurofibromatosis type 1 (NF1) gene during mouse embryonic development. Prog Brain Res, 1995. 105: p. 327-335 - 7.
Gutmann, D.H., et al., Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues. Cell Growth Differ, 1995. 6(3): p. 315-323 - 8.
Daston, M.M. and N. Ratner, Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev Dyn, 1992. 195(3): p. 216-226 - 9.
Ryu, H.H., et al., Enriched expression of NF1 in inhibitory neurons in both mouse and human brain. Mol Brain, 2019. 12(1): p. 60 - 10.
Andersen, L.B., et al., A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol, 1993. 13(1): p. 487-495 - 11.
Yunoue, S., et al., Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras. J Biol Chem, 2003. 278(29): p. 26958-26969 - 12.
Baizer, L., et al., Regulated expression of the neurofibromin type I transcript in the developing chicken brain. J Neurochem, 1993. 61(6): p. 2054-2060 - 13.
Huynh, D.P., T. Nechiporuk, and S.M. Pulst, Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. Dev Biol, 1994. 161(2): p. 538-551 - 14.
Nguyen, H.T., et al., Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice. Hum Mol Genet, 2017. 26(19): p. 3797-3807 - 15.
Guo, X., et al., Quantitative Analysis of Alternative Pre-mRNA Splicing in Mouse Brain Sections Using RNA In Situ Hybridization Assay. J Vis Exp, 2018(138) - 16.
Sharma, A., et al., Calcium-mediated histone modifications regulate alternative splicing in cardiomyocytes. Proc Natl Acad Sci U S A, 2014. 111(46): p. E4920-E4928 - 17.
Barron, V.A. and H. Lou, Alternative splicing of the neurofibromatosis type I pre-mRNA. Biosci Rep, 2012. 32(2): p. 131-138 - 18.
Zhu, H., et al., Regulation of neuron-specific alternative splicing of neurofibromatosis type 1 pre-mRNA. Mol Cell Biol, 2008. 28(4): p. 1240-1251 - 19.
Hinman, M.N., et al., All three RNA recognition motifs and the hinge region of HuC play distinct roles in the regulation of alternative splicing. Nucleic Acids Res, 2013. 41(9): p. 5049-5061 - 20.
Barron, V.A., et al., The neurofibromatosis type I pre-mRNA is a novel target of CELF protein-mediated splicing regulation. Nucleic Acids Res, 2010. 38(1): p. 253-264 - 21.
Fleming, V.A., et al., Alternative splicing of the neurofibromatosis type 1 pre-mRNA is regulated by the muscleblind-like proteins and the CUG-BP and ELAV-like factors. BMC Mol Biol, 2012. 13: p. 35 - 22.
Schor, I.E., L.I. Gomez Acuna, and A.R. Kornblihtt, Coupling between transcription and alternative splicing. Cancer Treat Res, 2013. 158: p. 1-24 - 23.
Hinman, M.N., et al., Neurofibromatosis type 1 alternative splicing is a key regulator of Ras signaling in neurons. Mol Cell Biol, 2014. 34(12): p. 2188-2197 - 24.
Zhou, H.L., et al., Hu proteins regulate alternative splicing by inducing localized histone hyperacetylation in an RNA-dependent manner. Proc Natl Acad Sci U S A, 2011. 108(36): p. E627-E635 - 25.
Bibel, M., et al., Generation of a defined and uniform population of CNS progenitors and neurons from mouse embryonic stem cells. Nat Protoc, 2007. 2(5): p. 1034-1043 - 26.
Serchov, T. and R. Heumann, Ras activity tunes the period and modulates the entrainment of the Suprachiasmatic clock. Front Neurol, 2017. 8: p. 264 - 27.
Marsden, W.N., Synaptic plasticity in depression: Molecular, cellular and functional correlates. Prog Neuropsychopharmacol Biol Psychiatry, 2013. 43: p. 168-184 - 28.
Costa, R.M., et al., Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat Genet, 2001. 27(4): p. 399-405